TWiV 808: Clinical update #81 with Dr. Daniel Griffin
Episode

TWiV 808: Clinical update #81 with Dr. Daniel Griffin

In COVID-19 clinical update #81, Daniel Griffin discusses vaccine boosters, vaccination during pregnancy, mRNA vaccine comparison, J&J vaccine booster, EUA expansion for Lilly monoclonals, remdesivir reduces risk of hospitalization, and anticoagulation regimens. Hosts: Daniel Griffin and Vincent Racaniello Subscribe (free): iTunes , Google Podcasts , RSS , email Become a patron of TWiV! Links for this episode Pfizer phase III results in 5-11 year olds (Pfizer) FDA authorizes booster (FDA) V-safe vaccine pregnancy registry (CDC) High antibody levels in cord blood (Am J Ob Gyn) mRNA vaccines compared (MMWR) Effectiveness of single shot J&J (medRxiv) J&J booster results (J&J) EUA expansion for Lilly mAbs (Lilly) Remdesivir reduces hospitalization risk (Gilead) DisCoVeRy on Remdesivir (Lancet) Prophylactic anticoagulant dosing (Eur Heart J) Letters read on TWiV 808 Timestamps by Jolene . Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]

Community discussion